Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Auditoria.AI launches Governed Autonomy to enable AI-driven finance with policy-based governance, reducing human approvals.

Others
26 May 2026
Auditoria.Ai
View Source
Neutral
pluang ai news

Auditoria.AI introduced Governed Autonomy, a new framework allowing AI agents to operate within enterprise-defined policies in finance, reducing the need for human approval on every transaction. This shift addresses governance challenges in AI deployment, enabling autonomous finance operations that maintain compliance and auditability across multiple platforms like Workday and SAP. The framework supports dynamic policy enforcement and identity-bound execution, aiming to transform AI from pilot projects to core operational tools. Auditoria's expanded capabilities in accounts payable workflows further demonstrate practical application of this governance model, enhancing transparency and control for finance teams.

More News

Bempedoic acid shows promise in lowering LDL-C in children and statin-intolerant adults, per Esperion data.

Bempedoic acid shows promise in lowering LDL-C in children and statin-intolerant adults, per Esperion data.

Esperion Therapeutics presented new data at the 2026 European Atherosclerosis Society Congress showing bempedoic acid effectively lowers LDL cholesterol in children aged 6-17 with familial hypercholesterolemia and is well tolerated. A secondary analy...

Market News
Bullish
20 minutes ago
Rhythm Pharmaceuticals to present at major healthcare conferences in June 2026

Rhythm Pharmaceuticals to present at major healthcare conferences in June 2026

Rhythm Pharmaceuticals announced that its CEO and CFO will participate in fireside chats at the Jefferies Global Healthcare Conference on June 4 and the Goldman Sachs Global Healthcare Conference on June 8, 2026. These events will be webcast and acce...

Market News
Neutral
20 minutes ago
Rani Therapeutics prices $20M direct offering of Class A common stock at market price

Rani Therapeutics prices $20M direct offering of Class A common stock at market price

Rani Therapeutics Holdings, a clinical-stage biotherapeutics company, announced a registered direct offering of Class A common stock priced at-the-market under Nasdaq rules. The offering includes 12.48 million shares and pre-funded warrants for 6.21 ...

Company Fundamentals
Bullish
20 minutes ago
Microchip launches 3.3 kV SiC power modules to boost efficiency in AI data center power delivery.

Microchip launches 3.3 kV SiC power modules to boost efficiency in AI data center power delivery.

Microchip Technology has introduced new 3.3 kV HV-D3 mSiC power modules designed to enhance solid-state transformers (SSTs) for AI hyperscale data centers. These modules integrate silicon carbide MOSFETs and Schottky diodes to improve power delivery ...

Others
Bullish
20 minutes ago
G. Willi-Food reports 9.7% rise in Q1 2026 gross profit with sales up 8.3%, net profit grows 3%.

G. Willi-Food reports 9.7% rise in Q1 2026 gross profit with sales up 8.3%, net profit grows 3%.

G. Willi-Food International Ltd. announced a strong first quarter for 2026, with sales increasing by 8.3% to NIS 157 million and gross profit rising 9.7% to NIS 49 million compared to the same period in 2025. Net profit grew by 3% to NIS 20.1 million...

Company Fundamentals
Bullish
30 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App